Neuraxis announces new cpt® category i code for percutaneous electrical nerve field stimulation

Carmel, ind., oct. 22, 2024 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced that the american medical association (ama) has established a new current procedural terminology (cpt) category i code for percutaneous electrical nerve field stimulation (penfs) procedures effective january 1, 2026.
NRXS Ratings Summary
NRXS Quant Ranking